title: Club drug use among young men who have sex with men in NYC: a preliminary epidemiological profile.
abstract: This paper describes findings from a study of young men who have sex with men (YMSM) in New York City. Using a cross-sectional design and a community-based targeted sampling approach, a total of 569 YMSM were recruited during 2000 and 2001 for a structured survey interview. High rates of lifetime exposure to a variety of club drugs (including methamphetamine, ketamine, and MDMA) are observed in the overall sample. Among those who use club drugs on a chronic basis (N=145), we found high rates of a prior suicide attempt (including high rates of multiple suicide attempts), high rates of lifetime exposure to multiple types of drugs, high rates of current poly drug use (including multiple types of club drugs), and high rates of current depressive symptoms. Chronic club drug users had a mean CES-D score of 8.5 and nearly two-thirds had a score of 7 or more. Although high rates of condom use are reported in some types of sexual exchanges, data show multiple types of sexual risk among chronic club drug users, including high rates of unprotected anal intercourse (UAI) with most frequent partners and comorbid drug use among both YMSM and their sexual partners.
authors.affiliation: Institute for International Research on Youth at Risk, National Development and Research Institutes, Inc., New York, New York 10010, USA. clatts@ndri.org
authors.forename: Michael C
authors.initials: MC
authors.lastname: Clatts
authors.forename: Lloyd A
authors.initials: LA
authors.lastname: Goldsamt
authors.forename: Huso
authors.initials: H
authors.lastname: Yi
mesh_terms: D000293:Adolescent; D000328:Adult; D000778:Anesthetics, Dissociative / Q000009:adverse effects* / Q000494:pharmacology*; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D002908:Chronic Disease; D003430:Cross-Sectional Studies; D006213:Hallucinogens / Q000009:adverse effects* / Q000494:pharmacology*; D006306:Health Surveys; D006716:Homosexuality; D006801:Humans; D007649:Ketamine / Q000009:adverse effects*; D008297:Male; D008694:Methamphetamine / Q000009:adverse effects*; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects* / Q000494:pharmacology*; D009519:New York City / Q000453:epidemiology; D011998:Recreation; D012309:Risk-Taking; D012749:Sexually Transmitted Diseases; D019966:Substance-Related Disorders / Q000453:epidemiology*; D013406:Suicide, Attempted; D014505:Urban Population
chemical_list: D000778:Anesthetics, Dissociative; D000697:Central Nervous System Stimulants; D006213:Hallucinogens; D008694:Methamphetamine; D007649:Ketamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine